Lyon, H.; Shome, A.; Rupenthal, I.D.; Green, C.R.; Mugisho, O.O.
Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy. Int. J. Mol. Sci. 2021, 22, 298.
https://doi.org/10.3390/ijms22010298
AMA Style
Lyon H, Shome A, Rupenthal ID, Green CR, Mugisho OO.
Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy. International Journal of Molecular Sciences. 2021; 22(1):298.
https://doi.org/10.3390/ijms22010298
Chicago/Turabian Style
Lyon, Heather, Avik Shome, Ilva D. Rupenthal, Colin R. Green, and Odunayo O. Mugisho.
2021. "Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy" International Journal of Molecular Sciences 22, no. 1: 298.
https://doi.org/10.3390/ijms22010298
APA Style
Lyon, H., Shome, A., Rupenthal, I. D., Green, C. R., & Mugisho, O. O.
(2021). Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy. International Journal of Molecular Sciences, 22(1), 298.
https://doi.org/10.3390/ijms22010298